Does Molina Medicare Cover Wegovy? Medicare Advantage Coverage Guide 2026
Medicare Advantage enrollees with Molina Medicare Advantage (administered by Molina Healthcare) commonly wonder whether Molina Medicare covers Wegovy (semaglutide 2.4mg). Here’s the overview: coverage depends on specific formulary placement and clinical criteria.
Molina Medicare’s Formulary Position on Wegovy
Molina Medicare Advantage operates with a drug formulary that classifies medications based on coverage level. For the 2026 plan year, Wegovy is generally listed at Tier 4 (Specialty) on most Molina Medicare plan variants.
Practical implications:
- Monthly copay: significant cost-sharing varying by plan variant and drug tier
- Prior authorization: Mandatory — your doctor must submit
- Quantity limits: Often enforced — standard 30-day supply limits
- Step therapy: Might need failed trial of first-line therapies first
The Medicare Part D coverage gap (donut hole), enrollees pay a larger share until catastrophic coverage kicks in.
Coverage for FDA-Approved vs. Off-Label Use
For chronic weight management (FDA-approved):
- Molina Medicare will generally authorize Wegovy for on-label use
- Documentation needed: HbA1c levels, prior medication history
- Success is more likely when used on-label
For weight loss (where applicable):
- CMS policy generally prohibits anti-obesity medications for weight loss alone
- That said: the Inflation Reduction Act broadened Part D coverage eligibility for certain anti-obesity drugs
- Molina Medicare could provide supplemental benefits that include weight management medications — check your Evidence of Coverage document
How Much Does Wegovy Cost With Molina Medicare
Estimating your real cost for Wegovy on Molina Medicare involves which Part D coverage phase you’re in.
| Coverage Phase | Approximate Cost |
|---|---|
| Initial Deductible ($545 in 2026) | 100% of cost: $1,300–$1,500/month |
| Initial Coverage | Tier 4/5 copay |
| Coverage Gap (Donut Hole) | 25% of cost |
| Catastrophic Coverage | $0 or small copay |
Starting in 2025, the annual cap limits your exposure — which significantly helps GLP-1 users.
Navigating the PA Process
- Ask for a tier exception — If Wegovy is non-preferred, the prescriber can submit a lower tier classification with supporting documentation
- Apply for patient assistance — Novo Nordisk provides patient assistance programs for eligible Medicare enrollees (note: savings cards typically don’t work with government plans)
- Shop during AEP — Open enrollment (Oct 15–Dec 7) lets you switch to a plan with better Wegovy coverage
- Check Low-Income Subsidy eligibility — If income-eligible can get LIS benefits that dramatically lower out-of-pocket expenses